Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$315.94 - $371.96 $1.74 Million - $2.05 Million
-5,500 Reduced 13.03%
36,700 $13.3 Million
Q2 2024

Aug 14, 2024

SELL
$324.3 - $354.67 $3.31 Million - $3.62 Million
-10,200 Reduced 19.47%
42,200 $14.4 Million
Q1 2024

May 15, 2024

SELL
$293.94 - $358.71 $8.52 Million - $10.4 Million
-29,000 Reduced 35.63%
52,400 $18.8 Million
Q4 2023

Feb 14, 2024

SELL
$253.85 - $299.46 $3.4 Million - $4.01 Million
-13,400 Reduced 14.14%
81,400 $24.4 Million
Q3 2023

Nov 14, 2023

BUY
$266.54 - $302.43 $13.1 Million - $14.9 Million
49,300 Added 108.35%
94,800 $25.9 Million
Q2 2023

Aug 14, 2023

BUY
$271.49 - $305.09 $12.4 Million - $13.9 Million
45,500 New
45,500 $13.9 Million
Q2 2019

Aug 14, 2019

SELL
$180.24 - $205.58 $36,048 - $41,116
-200 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$152.46 - $198.0 $30,492 - $39,600
200 New
200 $40,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $140B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.